Canopy Growth Stock Jumped 30% Last Month: What’s Going on?

Canopy Growth (TSX:WEED) stock is picking up traction again, making it an enticing weed play to buy on strength.

| More on:
Pot stocks are a riskier investment

Image source: Getty Images

Key Points

  • Canopy Growth (TSX:WEED) is a deeply discounted cannabis play — down >99% from 2018 highs but up ~30% in the past month after a strong quarter, trading around 0.9× P/S and 1.2× P/B with a ~$646M market cap.
  • The stock is highly volatile (beta ≈2.4) and remains speculative, so consider nibbling or dollar‑cost averaging and favor buying into continued fundamental improvement rather than chasing a bottom.

It’s been a long time since I’ve written about a pot stock. Since the cannabis boom went bust many years ago, it’s likely that many readers have also scratched pot producers, such as Canopy Growth (TSX:WEED), off their radars. If it’s been a while since you’ve tuned into the cannabis trade, you’re not alone. These days, WEED shares go for a mere $1.91 per share, a far cry from the more than $677 per share all-time highs hit back in 2018, when investors were growing euphoric over the legalization of cannabis in Canada.

In numerous prior pieces, I warned investors that cannabis was a commodity and that valuations should not be ignored. Fast forward a few years, and here we are, WEED stock, one of the highest flyers back in the day, has lost more than 99.5% of its value. And while it’s tough to catch a bottom, I finally think it’s time to revisit the intriguing cannabis producer now that its shares have probably overswung to the downside.

Canopy Growth is gaining again after a nice quarter

If you look at the 10-year chart, you’ll see an epic bursting of the bubble. However, if you zoom in a bit, things become more interesting, with shares now up over 30% in the past month. Indeed, the latest round of quarterly earnings was quite impressive.

However, volatility ensued as investors grew quite unsure as to what to do with their shares now that the firm has managed to top expectations on the sales front. While weed isn’t quite selling like pot cakes, I think that the recent bout of strength is difficult to ignore. Indeed, a nice rise in pot sales is remarkable, especially for a company that’s already been forgotten amid the continued implosion in the share price.

New CEO Luc Mongeau noted that the company has been “gaining share in high-demand categories,” which I think is nothing short of promising, especially with the rock-bottom price of admission. While it is still very much possible to lose money with a stock that goes for $1, I think that Canopy Growth is finally worth picking up again. The $646 million company isn’t booming anymore, but shares are oversold, and the latest growth spurt, I think, could be the start of an upward trend. At 0.9 times price to sales and 1.2 times price to book, WEED stock is actually a deep-value play.

Shares look cheap, but prepare for volatility

Of course, heightened volatility is a given, especially since the latest quarter has attracted many contrarian investors looking for a cannabis sector turnaround. With a 2.42 beta, the name is far too choppy for my liking.

However, if you are comfortable with the risk, I’m certainly not against betting on a turnaround, especially now that the trade has gone up in smoke in recent years. It’ll be tough to time a bottom, so I’d suggest nibbling small positions over the next year. If the next quarter impresses, perhaps buying into strength can make more sense than buying into further weakness. Indeed, dip-buying hasn’t worked out very well when it comes to pot stocks.

Fool contributor Joey Frenette has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

More on Cannabis Stocks

four people hold happy emoji masks
Dividend Stocks

Wary of Mining Companies? A Lower-Risk Way to Get in on the Gold and Silver Surge

Frenco-Nevada (TSX:FNV) stock might be a wiser way to play the run in gold prices this year.

Read more »

Cannabis smoke
Cannabis Stocks

Have Cannabis Stocks Totally Gone Up in Smoke?

Let's dive into whether Canadian cannabis stocks are still investable, and what investors should make of the recent volatility in…

Read more »

Researcher works in hemp field
Cannabis Stocks

1 Undervalued Cannabis Stock to Buy and Hold Over the Next Decade

Green Thumb is a beaten-down cannabis stock that trades at a compelling valuation in September 2025.

Read more »

Researcher works in hemp field
Cannabis Stocks

Pot Stocks Rallied Hard in August: Is There More to Come?

Tilray Brands (TSX:TLRY) and the broad basket of pot stocks could heat up from here.

Read more »

A cannabis plant grows.
Cannabis Stocks

These Threats Facing Canopy Growth Stock Could Justify Selling it

Let's dive into whether Canopy Growth (TSX:WEED) is a top stock investors should buy right now after its recent dip…

Read more »

A person holds a small glass jar of marijuana.
Stocks for Beginners

This BioCannabis Firm Could Explode with Product Approval

This cannabis stock used to be a major name, so where does it stand now?

Read more »

Medicinal research is conducted on cannabis.
Stocks for Beginners

This TSX Health-Care Stock Is a Long-Term Buy for Patient Investors

This TSX stock continues to be one of the best long-term opportunities, if you're patient.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

1 Cannabis Stock That’s My Speculative Sector Play

The cannabis boom has come and gone, but this cannabis stock may still have a chance to rise higher.

Read more »